As Vaccine Revenues Flow In, BioNTech Makes Rapid Oncology Push

German Biotech Initiates Multiple IO Programs

 
• By Alaric DeArment
  
shutterstock-264802244
BioNTech is doing a major push into immuno-oncology • Source: Shutterstock

More from Earnings

More from Business